Researchers assessed the effectiveness of a smartphone application for measuring sodium consumption.
Galimedix Therapeutics initiates Phase 1 study with oral small molecule, GAL-101, an amyloid beta (Aβ) aggregation modulator – Biotech Investments
EQS-News: Galimedix, Inc. / Key word(s): Study Galimedix Therapeutics initiates Phase 1 study with oral small molecule, GAL-101, an amyloid beta (Aβ) aggregation modulator 05.12.2024